<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">YD8PnmRsvK8z5ZrSRjgPMxt</article-id>
      <article-id pub-id-type="other">00003</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2007000100003</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(07)08800103</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2007000100003</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Caracter&#237;sticas card&#237;acas e metab&#243;licas de corredores de longa dist&#226;ncia do ambulat&#243;rio de cardiologia do esporte e exerc&#237;cio, de um hospital terci&#225;rio</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Azevedo</surname>
            <given-names>Luciene Ferreira</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brum</surname>
            <given-names>Patr&#237;cia Chakur</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosemblatt</surname>
            <given-names>Dudley</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Perlingeiro</surname>
            <given-names>Patr&#237;cia de S&#225;</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barretto</surname>
            <given-names>Ant&#244;nio Carlos Pereira</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Negr&#227;o</surname>
            <given-names>Carlos Eduardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matos</surname>
            <given-names>Luciana Diniz Nagem Janot de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">FM </institution>
        <institution content-type="orgdiv2">Hospital das Cl&#237;nicas</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Escola de Educa&#231;&#227;o F&#237;sica e Esporte </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>01</month>
        <year>2007</year>
      </pub-date>
      <volume>88</volume>
      <issue>1</issue>
      <fpage>17</fpage>
      <lpage>25</lpage>
      <history>
        <date date-type="rev-recd">
          <day>20</day>
          <month>12</month>
          <year>2005</year>
        </date>
        <date date-type="received">
          <day>02</day>
          <month>09</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>01</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>OBJETIVO: Caracterizar par&#226;metros card&#237;acos, eletrocardiogr&#225;ficos e funcionais, e respostas cardiopulmonares ao exerc&#237;cio em corredores de longa dist&#226;ncia brasileiros, acompanhados no Ambulat&#243;rio de Cardiologia do Esporte e Exerc&#237;cio de um hospital terci&#225;rio. M&#201;TODOS: De uma popula&#231;&#227;o inicial de 443 atletas, de ambos os sexos, de diferentes modalidades esportivas, foram avaliados 162 (37%) corredores de longa dist&#226;ncia, do sexo masculino, com idade variando entre quatorze e 67 anos. Registros eletrocardiogr&#225;ficos (doze deriva&#231;&#245;es) e ecocardiogr&#225;ficos (modos mono e bidimensional) foram realizados em repouso. Respostas cardiopulmonares foram avaliadas durante teste em esteira rolante, com protocolo em rampa. RESULTADOS: Altera&#231;&#245;es metab&#243;licas e doen&#231;as cardiovasculares foram diagnosticadas em 17% e 9% dos corredores, respectivamente. Bradicardia sinusal e hipertrofia ventricular esquerda foram verificadas em 62% e 33% dos corredores, respectivamente. Altera&#231;&#245;es estruturais, como cavidade ventricular &gt; 55mm, espessura relativa de parede &gt; 0,44 e &#237;ndice de massa ventricular &gt; 134g/m2 foram encontradas em 15%, 11% e 7% dos corredores, respectivamente. Fra&#231;&#227;o de eje&#231;&#227;o &lt; 55% foi observada em 4% dos corredores. O consumo de oxig&#234;nio pico (VO2pico) diminuiu a partir de 41 anos, embora o limiar anaer&#243;bio relativo ao VO2pico tenha se mantido inalterado com a idade. CONCLUS&#195;O: Bradicardia de repouso e hipertrofia ventricular esquerda s&#227;o as adapta&#231;&#245;es cardiovasculares mais freq&#252;entes em corredores de longa dist&#226;ncia brasileiros acompanhados no Ambulat&#243;rio de Cardiologia do Esporte e Exerc&#237;cio. Apesar da diminui&#231;&#227;o do VO2pico a partir de 41 anos, h&#225; manuten&#231;&#227;o do consumo de oxig&#234;nio relativo no limiar anaer&#243;bio nesses corredores.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Eletrocardiografia</kwd>
        <kwd>freq&#252;&#234;ncia card&#237;aca</kwd>
        <kwd>hipertrofia ventricular esquerda</kwd>
        <kwd>consumo de oxig&#234;nio</kwd>
        <kwd>limiar anaer&#243;bio</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>07</day>
        <month>03</month>
        <year>2007</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>ARTIGO ORIGINAL</bold>
    </p>
    <p>Caracter&#237;sticas card&#237;acas e metab&#243;licas de corredores de longa dist&#226;ncia do ambulat&#243;rio de cardiologia do esporte e exerc&#237;cio, de um hospital terci&#225;rio</p>
    <p>
      <bold>Luciene Ferreira Azevedo; Patr&#237;cia Chakur Brum; Dudley Rosemblatt; Patr&#237;cia de S&#225; Perlingeiro; Ant&#244;nio Carlos Pereira Barretto; Carlos Eduardo Negr&#227;o; Luciana Diniz Nagem Janot de Matos</bold>
    </p>
    <p> Instituto do Cora&#231;&#227;o do Hospital das Cl&#237;nicas &#150; FMUSP e Escola de Educa&#231;&#227;o F&#237;sica e Esporte da Universidade de S&#227;o Paulo - S&#227;o Paulo, SP</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>OBJETIVO:</bold> Caracterizar par&#226;metros card&#237;acos, eletrocardiogr&#225;ficos e funcionais, e respostas cardiopulmonares ao exerc&#237;cio em corredores de longa dist&#226;ncia brasileiros, acompanhados no Ambulat&#243;rio de Cardiologia do Esporte e Exerc&#237;cio de um hospital terci&#225;rio. </p>
    <p><bold>M&#201;TODOS:</bold> De uma popula&#231;&#227;o inicial de 443 atletas, de ambos os sexos, de diferentes modalidades esportivas, foram avaliados 162 (37%) corredores de longa dist&#226;ncia, do sexo masculino, com idade variando entre quatorze e 67 anos. Registros eletrocardiogr&#225;ficos (doze deriva&#231;&#245;es) e ecocardiogr&#225;ficos (modos mono e bidimensional) foram realizados em repouso. Respostas cardiopulmonares foram avaliadas durante teste em esteira rolante, com protocolo em rampa. </p>
    <p><bold>RESULTADOS:</bold> Altera&#231;&#245;es metab&#243;licas e doen&#231;as cardiovasculares foram diagnosticadas em 17% e 9% dos corredores, respectivamente. Bradicardia sinusal e hipertrofia ventricular esquerda foram verificadas em 62% e 33% dos corredores, respectivamente. Altera&#231;&#245;es estruturais, como cavidade ventricular <underline>&gt;</underline> 55mm, espessura relativa de parede <underline>&gt;</underline> 0,44 e &#237;ndice de massa ventricular <underline>&gt;</underline> 134g/m2 foram encontradas em 15%, 11% e 7% dos corredores, respectivamente. Fra&#231;&#227;o de eje&#231;&#227;o &lt; 55% foi observada em 4% dos corredores. O consumo de oxig&#234;nio pico (VO2pico) diminuiu a partir de 41 anos, embora o limiar anaer&#243;bio relativo ao VO2pico tenha se mantido inalterado com a idade. </p>
    <p><bold>CONCLUS&#195;O:</bold> Bradicardia de repouso e hipertrofia ventricular esquerda s&#227;o as adapta&#231;&#245;es cardiovasculares mais freq&#252;entes em corredores de longa dist&#226;ncia brasileiros acompanhados no Ambulat&#243;rio de Cardiologia do Esporte e Exerc&#237;cio. Apesar da diminui&#231;&#227;o do VO2pico a partir de 41 anos, h&#225; manuten&#231;&#227;o do consumo de oxig&#234;nio relativo no limiar anaer&#243;bio nesses corredores.</p>
    <p><bold>Palavras-chave:</bold> Eletrocardiografia, freq&#252;&#234;ncia card&#237;aca, hipertrofia ventricular esquerda, consumo de oxig&#234;nio, limiar anaer&#243;bio.</p>
    <p>O treinamento f&#237;sico intenso realizado por atletas, visando &#224; busca do melhor rendimento esportivo, exp&#245;e o cora&#231;&#227;o a intensas sobrecargas ao longo de meses ou anos. Essa freq&#252;ente exposi&#231;&#227;o a sobrecargas resulta em altera&#231;&#245;es no automatismo card&#237;aco, como bradicardia de repouso, e altera&#231;&#227;o de condu&#231;&#227;o atrioventricular, despolariza&#231;&#227;o e repolariza&#231;&#227;o ventricular<sup>1,2</sup>. Os ajustes estruturais do cora&#231;&#227;o tamb&#233;m s&#227;o marcantes, podendo levar a aumentos de at&#233; 85% na massa do ventr&#237;culo esquerdo<sup>3</sup>. Apesar de essas altera&#231;&#245;es funcionais e estruturais serem devidamente documentadas, ainda s&#227;o desconhecidos os seus limites de normalidade e suas conseq&#252;&#234;ncias em longo prazo.</p>
    <p>A avalia&#231;&#227;o cl&#237;nica/cardiol&#243;gica do atleta &#233; uma conduta m&#233;dica muito importante, possibilitando: A) identificar o grau de altera&#231;&#245;es card&#237;acas em decorr&#234;ncia do treinamento f&#237;sico intenso e B) diagnosticar doen&#231;as card&#237;acas preexistentes<sup>4</sup>. Afastar a presen&#231;a de doen&#231;as card&#237;acas preexistentes &#233; de fundamental import&#226;ncia na preven&#231;&#227;o de eventos fatais em atletas. Apesar do baixo risco de morte s&#250;bita em atletas (uma em cada trezentos mil atletas por ano)<sup>5,6</sup>, a presen&#231;a de uma doen&#231;a cardiovascular oculta eleva o risco de um evento card&#237;aco fatal em at&#233; cem vezes. Portanto, saber diferenciar as altera&#231;&#245;es desencadeadas pelo treinamento f&#237;sico das altera&#231;&#245;es patol&#243;gicas preexistentes &#233; o primeiro desafio para o m&#233;dico cardiologista do esporte<sup>4</sup>.</p>
    <p>No Brasil, h&#225; escassez de dados sobre a condi&#231;&#227;o de sa&#250;de e as caracter&#237;sticas do sistema cardiovascular do atleta. Somando-se a isso, n&#227;o h&#225; estat&#237;stica sobre as doen&#231;as mais freq&#252;entes e nem sobre a taxa de morte s&#250;bita nesses atletas. Nos Estados Unidos, a cardiomiopatia hipertr&#243;fica encabe&#231;a a lista de doen&#231;as respons&#225;veis pela morte s&#250;bita em atletas; enquanto na It&#225;lia, a displasia arritmog&#234;nica do ventr&#237;culo direito<sup>7,8</sup> &#233; a mais freq&#252;entemente encontrada. Esses resultados evidenciam que as caracter&#237;sticas cardiovasculares de atletas de alto n&#237;vel podem variar entre os pa&#237;ses.</p>
    <p>Na tentativa de ampliar o nosso conhecimento sobre as caracter&#237;sticas cardiovasculares dos atletas brasileiros, objetivamos caracterizar neste estudo: 1) a estrutura e funcionamento do cora&#231;&#227;o de atletas corredores de longa dist&#226;ncia brasileiros, matriculados no Ambulat&#243;rio de Cardiologia do Esporte e Exerc&#237;cio de um hospital terci&#225;rio da cidade de S&#227;o Paulo; e 2) a capacidade cardiopulmonar e o perfil metab&#243;lico durante o exerc&#237;cio f&#237;sico progressivo m&#225;ximo nesses atletas.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>De um registro de 443 atletas (342 homens e 101 mulheres) matriculados no Ambulat&#243;rio de Cardiologia do Esporte e Exerc&#237;cio de um hospital terci&#225;rio da cidade de S&#227;o Paulo, Brasil, distribu&#237;dos em dezenove modalidades, conforme apresentado na <xref ref-type="fig" rid="fig01">figura 1</xref>, foram selecionados 162 corredores de longa dist&#226;ncia (&gt; 3.000 m) do sexo masculino, com idade variando de quatorze a 67 anos. O tempo m&#233;dio de treinamento para competi&#231;&#227;o dos atletas foi de 11,2 &#177; 0,7 anos. Eles realizavam de tr&#234;s a sete sess&#245;es de treino por semana, com volume que variou de 30 a 160 km por semana, e intensidade moderada (entre as freq&#252;&#234;ncias card&#237;acas correspondentes ao limiar anaer&#243;bio e o ponto de compensa&#231;&#227;o respirat&#243;ria) e alta (freq&#252;&#234;ncia card&#237;aca acima do ponto de compensa&#231;&#227;o respirat&#243;ria). A maioria dos atletas inclu&#237;dos era amadora.</p>
    <fig id="fig01">
      <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gf01.jpg"/></fig>
    <p><italic>Avalia&#231;&#227;o eletrocardiogr&#225;fica</italic> - O eletrocardiograma foi realizado na posi&#231;&#227;o supina ap&#243;s cinco minutos em repouso, com doze deriva&#231;&#245;es-padr&#227;o, velocidade de 25 mm/segundo e voltagem de 10 mm/mV (Hewlett Packard, HP 708), como parte do exame de rotina para a matr&#237;cula no Ambulat&#243;rio de Cardiologia do Esporte e Exerc&#237;cio. A bradicardia sinusal em repouso foi caracterizada em duas faixas de freq&#252;&#234;ncia card&#237;aca: &lt; 60bpm e &lt; 50bpm. O &#237;ndice utilizado para verificarmos hipertrofia ventricular esquerda foi o de Sokolow-Lion<sup>9</sup>.</p>
    <p><italic>Avalia&#231;&#227;o morfol&#243;gica e funcional do cora&#231;&#227;o</italic> - A morfologia e a fun&#231;&#227;o do ventr&#237;culo esquerdo foram avaliadas por ecocardiograma bidimensional (Sonos 5500, Hewlett Packard, - Massachusetts - EUA). Os di&#226;metros da cavidade do ventr&#237;culo esquerdo (VE) foram obtidos pelo modo M, guiadas pelo modo bidimensional, conforme as orienta&#231;&#245;es da Sociedade Americana de Ecocardiografia<sup>10</sup>. A massa do ventr&#237;culo esquerdo foi calculada pela f&#243;rmula Cubo<sup>11</sup>: 0,8[1,04(DDVE + PP + SV)3 &#150; DDVE3] + 0,6g, a qual foi expressa em raz&#227;o da &#225;rea de superf&#237;cie corporal (&#237;ndice de massa do ventr&#237;culo esquerdo, g/m2). A espessura relativa de parede (ERP) foi calculada como: (septo ventricular + parede posterior)/di&#226;metro diast&#243;lico do ventr&#237;culo esquerdo, com distin&#231;&#227;o entre hipertrofia exc&#234;ntrica (ERP &lt; 0,44) e conc&#234;ntrica (ERP <underline>&gt;</underline> 0,44). Os volumes ventriculares foram calculados usando a f&#243;rmula de Teichholz: [7/(2,4 + DDVE) x DDVE3] e foram usados para calcular a fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo (FEVE - %). Hipertrofia ventricular esquerda foi definida com valores de septo ventricular e/ou parede posterior do ventr&#237;culo esquerdo &gt;13 mm e &#237;ndice de massa do ventr&#237;culo esquerdo &gt; 134g/m2. Anormal dilata&#231;&#227;o da cavidade ventricular esquerda foi definida com valores de di&#226;metro diast&#243;lico do ventr&#237;culo esquerdo (DDVE) &gt; 60 mm<sup>12-14</sup>.</p>
    <p><italic>Avalia&#231;&#227;o funcional cardiopulmonar</italic> - A avalia&#231;&#227;o da capacidade funcional m&#225;xima dos atletas foi realizada por meio de um teste cardiopulmonar em esteira rolante (Quinton Q65, model 645, Quinton Instruments Co., Washington, EUA), com protocolo em rampa at&#233; a exaust&#227;o. Os incrementos de carga foram realizados a cada minuto e definidos de acordo com a capacidade f&#237;sica de cada atleta, de tal forma que o tempo total de exerc&#237;cio variasse entre oito e dezessete minutos, conforme previamente descrito<sup>15</sup>. Os atletas foram orientados quanto &#224; dieta pr&#233;via ao teste e a n&#227;o-realiza&#231;&#227;o de exerc&#237;cio 24 horas antes do teste.</p>
    <p>O consumo de oxig&#234;nio (VO2) e a produ&#231;&#227;o de di&#243;xido de carbono (VCO2) foram determinados pela m&#233;dia da troca gasosa respira&#231;&#227;o &#150; a &#150; respira&#231;&#227;o por meio de sistema computadorizado (Vm&#225;x, series 229 - SensorMedics Corporation, California, EUA). O consumo pico de oxig&#234;nio (VO2pico) foi definido como o m&#225;ximo VO2 medido no final do exerc&#237;cio, quando o atleta n&#227;o conseguia mais manter a carga imposta pelo erg&#244;metro. O limiar anaer&#243;bio foi determinado pela perda de linearidade entre a VCO2 e o VO2 , o ponto no qual o equivalente ventilat&#243;rio de oxig&#234;nio (VE/VO2) ou a press&#227;o expirada final de oxig&#234;nio (PetO2) atingia o seu menor valor antes de come&#231;ar a aumentar durante o teste. O ponto de compensa&#231;&#227;o respirat&#243;ria foi determinado no ponto em que o equivalente ventilat&#243;rio de di&#243;xido de carbono (VE/VCO2) atingia o seu n&#237;vel mais baixo antes de come&#231;ar a aumentar e em que a press&#227;o expirada final de di&#243;xido de carbono (PetCO2) atingia o seu valor m&#225;ximo antes de diminuir<sup>16</sup>.</p>
    <p>A freq&#252;&#234;ncia card&#237;aca foi monitorada ao longo de todo o teste por meio de eletrocardiograma de doze deriva&#231;&#245;es (Marquette Medical Systems, InC. CardioSoft, Wisconsin, EUA). A press&#227;o arterial foi aferida por meio de esfigmoman&#244;metro de coluna merc&#250;rio antes do in&#237;cio do teste e durante o exerc&#237;cio.</p>
    <p><italic>An&#225;lise estat&#237;stica - </italic>Os dados s&#227;o apresentados como m&#233;dia &#177; erro padr&#227;o da m&#233;dia. Para identificar as poss&#237;veis diferen&#231;as entre as faixas et&#225;rias foi utilizada an&#225;lise de vari&#226;ncia de um caminho (one-way ANOVA &#150; Software Statistica), seguida do teste de post-hoc de Scheff&#233;. Foi adotado um p &lt; 0,05 para signific&#226;ncia estat&#237;stica.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p><italic>Par&#226;metros cl&#237;nicos/cardiol&#243;gicos - </italic>Dentre os 162 corredores avaliados, 27 (17%) apresentaram altera&#231;&#245;es metab&#243;licas (seis: anemia ferropriva, um: hipotireoidismo, dezessete: dislipidemia e tr&#234;s: glicemia elevada) e quinze (9%) apresentaram doen&#231;as cardiovasculares (treze: hipertens&#227;o arterial sist&#234;mica e dois: doen&#231;a de chagas, sendo um atleta com forma indeterminada e um com miocardiopatia). Apenas o atleta com miocardiopatia chag&#225;sica foi exclu&#237;do da amostra e desqualificado para a pr&#225;tica de esportes competitivos.</p>
    <p>As caracter&#237;sticas f&#237;sicas e hemodin&#226;micas em repouso nas diferentes faixas et&#225;rias s&#227;o apresentadas na <xref ref-type="table" rid="tab01">tabela 1</xref>. A distribui&#231;&#227;o porcentual dos atletas nas diferentes faixas et&#225;rias foi: at&#233; 30 anos (26%), 31 a 40 anos (32%), 41 a 50 anos (24%), 51 a 60 anos (14%) e 61 a 70 anos (4%). O grupo at&#233; 30 anos apresentou &#237;ndice de massa corporal (IMC) significativamente menor que os outros grupos de 31 a 40 anos, 41 a 50 anos, 51 a 60 anos, e 61 a 70 anos (21 &#177; 0,3 versus 22 &#177; 0,3; 23 &#177; 0,4; 24 &#177; 0,5; 24 &#177; 1,0; p = 0,0001), respectivamente. Os valores de press&#227;o arterial sist&#243;lica, diast&#243;lica e freq&#252;&#234;ncia card&#237;aca n&#227;o foram diferentes entre os atletas nas diferentes faixas et&#225;rias. Verificamos que 86% dos atletas apresentaram freq&#252;&#234;ncia card&#237;aca &lt; 60 bpm (m&#233;dia de 49 &#177; 0,5 bpm), mas, quando consideramos freq&#252;&#234;ncias card&#237;acas &lt; 50 bpm (m&#233;dia de 44 &#177; 0,1 bpm), esse porcentual &#233; reduzido para 62%. Hipertrofia ventricular esquerda foi verificada em 33% dos corredores e repolariza&#231;&#227;o precoce em 20% (<xref ref-type="fig" rid="fig02">fig. 2</xref>). A preval&#234;ncia dessas altera&#231;&#245;es foi mantida quando a an&#225;lise do eletrocardiograma foi realizada por faixa et&#225;ria (<xref ref-type="fig" rid="fig03">fig. 3</xref>).</p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gt01.jpg"/></table-wrap>
    <fig id="fig02">
      <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gf02.jpg"/></fig>
    <fig id="fig03">
      <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gf03.jpg"/></fig>
    <p>Os par&#226;metros ecocardiogr&#225;ficos n&#227;o mostraram diferen&#231;as significativas entre os grupos de corredores nas diferentes faixas et&#225;rias, com exce&#231;&#227;o da espessura relativa de parede (ERP), que foi significativamente maior no grupo 51 a 60 anos, comparado ao grupo at&#233; 30 anos (0,41 &#177; 0,02 versus 0,36 &#177; 0,01; p = 0,04) (<xref ref-type="table" rid="tab02">tab. 2</xref>). Oito fundistas (11%) apresentaram valores de espessura relativa de parede (ERP) <underline>&gt;</underline> 0,44, caracterizando padr&#227;o conc&#234;ntrico de hipertrofia<sup>17</sup>. Desses oito corredores, seis (75%) eram hipertensos. </p>
    <table-wrap id="tab02">
      <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gt02.jpg"/></table-wrap>
    <p>Em 64 atletas (85%), o tamanho da cavidade ventricular esquerda (di&#226;metro diast&#243;lico do ventr&#237;culo esquerdo) estava dentro dos valores de normalidade (<underline>&lt;</underline> 54 mm). No entanto, onze fundistas (15%) apresentaram valores acima do limite superior da normalidade (<underline>&gt;</underline> 55 mm)<sup>14,17</sup>. As maiores medidas do septo ventricular e parede posterior do ventr&#237;culo esquerdo n&#227;o excederam o limite superior da normalidade (13 mm)<sup>14</sup>. Com rela&#231;&#227;o ao &#237;ndice de massa ventricular esquerda, cinco fundistas (7%) excederam o limite da normalidade (&gt; 134 g/m<sup>2</sup>)<sup>18</sup>. A fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo estava abaixo do limite da normalidade (&lt; 55%)<sup>14,18</sup> em apenas tr&#234;s atletas (4%), sendo um na faixa et&#225;ria de 31 a 40 anos, um de 51 a 60 anos e um de 61 a 70 anos.</p>
    <p><italic>Par&#226;metros cardiovasculares e metab&#243;licos durante a avalia&#231;&#227;o funcional cardiopulmonar - </italic>Os valores de freq&#252;&#234;ncia card&#237;aca e consumo de oxig&#234;nio no limiar anaer&#243;bio, no ponto de compensa&#231;&#227;o respirat&#243;ria e no pico do esfor&#231;o, nas diferentes faixas et&#225;rias, s&#227;o mostrados nas <xref ref-type="table" rid="tab03">tabelas 3</xref> e <xref ref-type="table" rid="tab04">4</xref>, respectivamente. As freq&#252;&#234;ncias card&#237;acas no limiar anaer&#243;bio, nas diferentes faixas et&#225;rias, foram semelhantes tanto em valores absolutos (147 &#177; 2; 142 &#177; 2; 137 &#177; 3; 140 &#177; 3; 131 &#177; 6, p &gt; 0,05) quanto em valores relativos (porcentual da freq&#252;&#234;ncia card&#237;aca pico). A freq&#252;&#234;ncia card&#237;aca absoluta no ponto de compensa&#231;&#227;o respirat&#243;ria foi significativamente menor nos grupos 31 a 40 anos, 41 a 50 anos, 51 a 60 anos, e 61 a 70 anos, comparado ao grupo at&#233; 30 anos (167 &#177; 2; 165 &#177; 2; 161 &#177; 3; 158 &#177; 5 versus 175 &#177; 2; p &lt; 0,05), respectivamente. No entanto, quando a freq&#252;&#234;ncia card&#237;aca foi expressa em rela&#231;&#227;o ao porcentual da freq&#252;&#234;ncia card&#237;aca pico, n&#227;o se observou diferen&#231;a significativa entre as faixas et&#225;rias. A freq&#252;&#234;ncia card&#237;aca pico diminuiu significativamente nos grupos 31 a 40 anos, 41 a 50 anos, 51 a 60 anos, e 61 a 70 anos, comparado ao grupo de at&#233; 30 anos (176 &#177; 1; 175 &#177; 2; 171 &#177; 3; 167 &#177; 5 versus 184 &#177; 2; p &lt; 0,05), respectivamente. Quando a freq&#252;&#234;ncia card&#237;aca pico foi apresentada como valor porcentual da freq&#252;&#234;ncia card&#237;aca m&#225;xima predita para a idade<sup>19</sup>, os atletas dos grupos 41 a 50 anos, 51 a 60 anos e 61 a 70 anos apresentaram valores significativamente maiores que o grupo at&#233; 30 anos e o grupo 31 a 40 anos (100 &#177; 1; 103 &#177; 1; 103 &#177; 3 versus 94 &#177; 1 e 95 &#177; 1; p &lt; 0,05), respectivamente.</p>
    <table-wrap id="tab03">
      <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gt03.jpg"/></table-wrap>
    <table-wrap id="tab04">
      <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gt04.jpg"/></table-wrap>
    <p>O consumo de oxig&#234;nio absoluto no limiar anaer&#243;bio foi significativamente menor no grupo 51 a 60 anos comparado ao grupo at&#233; 30 anos (33 &#177; 1 versus 40 &#177; 1; p &lt; 0,05). No entanto, quando o consumo de oxig&#234;nio foi expresso em rela&#231;&#227;o ao consumo pico de oxig&#234;nio, essa diferen&#231;a n&#227;o foi mais observada. O consumo de oxig&#234;nio absoluto no ponto de compensa&#231;&#227;o respirat&#243;ria diminuiu significativamente nos grupos 41 a 50 anos, 51 a 60 anos e 61 a 70 anos, comparado ao grupo at&#233; 30 anos (46 &#177; 1; 44 &#177; 1; 42 &#177; 3 versus 54 &#177; 1; p &lt; 0,05), respectivamente. Por&#233;m, quando esses valores foram expressos em rela&#231;&#227;o ao consumo pico de oxig&#234;nio, essas diferen&#231;as n&#227;o foram mais verificadas. O consumo pico de oxig&#234;nio diminuiu significativamente nos grupos 41 a 50 anos, 51 a 60 anos e 61 a 70 anos, comparado ao grupo at&#233; 30 anos (52 &#177; 0,2; 48 &#177; 0,4; 46 &#177; 1,1 versus 60 &#177; 0,2; p &lt; 0,05), respectivamente. Entretanto, os atletas de 41 a 50 anos atingiram valores de consumo de oxig&#234;nio m&#225;ximo predito para a idade significativamente maiores que os atletas at&#233; 30 anos (150 &#177; 1 versus 128 &#177; 0,5; p &lt; 0,05). Os atletas nos grupos 51 a 60 anos e 61 a 70 anos apresentaram maiores valores de consumo de oxig&#234;nio m&#225;ximo predito para idade comparado ao grupo 31 a 40 anos (158 &#177; 1; 172 &#177; 3 versus 135 &#177; 0,4; p &lt; 0,05).</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Os resultados deste estudo mostram que a bradicardia sinusal, a hipertrofia ventricular esquerda e a repolariza&#231;&#227;o precoce s&#227;o as altera&#231;&#245;es eletrocardiogr&#225;ficas mais freq&#252;entes em atletas corredores fundistas, do sexo masculino, registrados no Ambulat&#243;rio de Cardiologia do Esporte e Exerc&#237;cio de um hospital terci&#225;rio da cidade de S&#227;o Paulo. Al&#233;m disso, verificamos que eles apresentam, na sua maioria, par&#226;metros ecocardiogr&#225;ficos dentro do limite da normalidade. Este estudo mostra ainda que, apesar da diminui&#231;&#227;o da freq&#252;&#234;ncia card&#237;aca e do consumo de oxig&#234;nio em valores absolutos no limiar anaer&#243;bio e no ponto de compensa&#231;&#227;o respirat&#243;ria, esses par&#226;metros n&#227;o s&#227;o alterados pela idade quando expressos em valores relativos ao pico do exerc&#237;cio. Finalmente, o nosso estudo mostra que, embora haja diminui&#231;&#227;o nos valores absolutos de freq&#252;&#234;ncia card&#237;aca e consumo de oxig&#234;nio no pico do exerc&#237;cio com o avan&#231;o da idade, em termos relativos ao predito para a idade, esses par&#226;metros est&#227;o aumentados nos atletas mais velhos.</p>
    <p>A bradicardia sinusal corresponde &#224; principal modifica&#231;&#227;o eletrocardiogr&#225;fica de repouso encontrada em atletas<sup>20</sup>. Maron e Mitchell<sup>21</sup> demonstraram que 65% dos atletas de resist&#234;ncia aer&#243;bica apresentam freq&#252;&#234;ncia card&#237;aca menor que 50 bpm. Os nossos resultados confirmam esses achados. Portanto, essa adapta&#231;&#227;o card&#237;aca deve ser considerada uma variante do normal em atletas de alto rendimento. Mais que isso, ela &#233; uma das caracter&#237;sticas mais marcantes da efic&#225;cia do treinamento f&#237;sico aer&#243;bico.</p>
    <p>Alguns autores<sup>22-24</sup> t&#234;m observado que o treinamento f&#237;sico de alta intensidade em atletas de elite pode alterar o balan&#231;o auton&#244;mico card&#237;aco e, com isso, o grau de bradicardia de repouso. Por exemplo, durante o per&#237;odo competitivo, pode haver intensifica&#231;&#227;o da atividade nervosa simp&#225;tica no cora&#231;&#227;o. Ao contr&#225;rio, no per&#237;odo de treino menos intenso, os atletas apresentam predom&#237;nio da atividade nervosa parassimp&#225;tica. Esses conhecimentos podem explicar os diferentes n&#237;veis de bradicardia verificados em atletas nos diferentes estudos, inclusive no presente estudo, independentemente da idade.</p>
    <p>A grande incid&#234;ncia de hipertrofia ventricular esquerda e repolariza&#231;&#227;o precoce em atletas de resist&#234;ncia aer&#243;bia, observada por meio da an&#225;lise eletrocardiogr&#225;fica no presente estudo, confirma os resultados descritos previamente<sup>20</sup>. No entanto, a incid&#234;ncia de modifica&#231;&#245;es na despolariza&#231;&#227;o, condu&#231;&#227;o e repolariza&#231;&#227;o ventricular foi menor em nosso estudo, comparada com a de outros estudos<sup>20,25</sup>. Em atletas, as altera&#231;&#245;es eletrocardiogr&#225;ficas s&#227;o bastante freq&#252;entes, mas em geral inespec&#237;ficas. Isoladas, n&#227;o t&#234;m signific&#226;ncia cl&#237;nica importante. Entretanto, essas adapta&#231;&#245;es correlacionam-se diretamente com o tempo e a intensidade de treinamento f&#237;sico, al&#233;m do tipo de esporte praticado pelos atletas<sup>20</sup>. Sua grande caracter&#237;stica &#233; a revers&#227;o diante de esfor&#231;o f&#237;sico e interrup&#231;&#227;o do treinamento f&#237;sico.</p>
    <p>Com rela&#231;&#227;o aos par&#226;metros ecocardiogr&#225;ficos, embora 15% dos atletas tenham apresentado valores de di&#226;metro diast&#243;lico do ventr&#237;culo esquerdo superiores aos da normalidade (55-60 mm), nenhum atleta apresentou valores extremamente elevados (&gt; 60 mm), o que levantaria quest&#245;es sobre a necessidade de diagn&#243;stico diferencial entre o cora&#231;&#227;o de atleta e a doen&#231;a card&#237;aca estrutural. Alguns fatores podem ter contribu&#237;do para que apenas 15% dos nossos atletas apresentassem adapta&#231;&#245;es mais acentuadas, conhecidas como "cora&#231;&#227;o de atleta": a) somente 16% da amostra eram constitu&#237;dos de atletas de elite. Vale a pena ressaltar que atletas de elite s&#227;o aqueles engajados em periodiza&#231;&#227;o sistematizada do treinamento f&#237;sico, envolvendo grande volume e intensidade de treino. Al&#233;m disso, o atleta de elite se destaca entre os primeiros colocados do ranking anual da federa&#231;&#227;o. Nesse contexto, Fagard<sup>26</sup> sugeriu que somente o treinamento muito intenso pode provocar adapta&#231;&#245;es morfol&#243;gicas significativas no ventr&#237;culo esquerdo, em conseq&#252;&#234;ncia da sobrecarga de volume e press&#227;o arterial gerados durante as sess&#245;es de treinamento; b) nossa amostra foi essencialmente composta de atletas corredores. Isso tem implica&#231;&#245;es fisiol&#243;gicas, visto que adapta&#231;&#245;es morfol&#243;gicas card&#237;acas de maior magnitude s&#227;o observadas em atletas que associam componentes de resist&#234;ncia aer&#243;bia e for&#231;a em seus treinamentos, como os ciclistas e remadores<sup>3,20,26-28</sup>. N&#227;o se pode, contudo, excluir a influ&#234;ncia gen&#233;tica na express&#227;o do remodelamento estrutural card&#237;aco, conforme descrito anteriormente<sup>29</sup>. Hernandez e cols.<sup>29</sup> demonstraram que o gen&#243;tipo de dele&#231;&#227;o da enzima conversora da angiotensina (ECA/DD) estava associado com o grau de hipertrofia ventricular esquerda induzida pelo exerc&#237;cio, em atletas de endurance. &#201; poss&#237;vel que somente alguns dos nossos atletas apresentassem essa caracter&#237;stica gen&#233;tica e, portanto, maior predisposi&#231;&#227;o para hipertrofia card&#237;aca. </p>
    <p>Um dos crit&#233;rios ecocardiogr&#225;ficos utilizados para diferenciar a hipertrofia ventricular patol&#243;gica da hipertrofia fisiol&#243;gica &#233; o aumento da espessura relativa de parede (ERP)<sup>30</sup>. Em nosso estudo, 11% dos corredores apresentavam valores de ERP aumentados, sugerindo remodelamento conc&#234;ntrico, isto &#233;, maior espessura da parede em rela&#231;&#227;o ao di&#226;metro diast&#243;lico do ventr&#237;culo esquerdo. &#201; pouco prov&#225;vel que o tipo de treinamento f&#237;sico tenha influenciado essa adapta&#231;&#227;o card&#237;aca, uma vez que a corrida de fundo &#233; um est&#237;mulo para o remodelamento exc&#234;ntrico card&#237;aco<sup>3</sup>. &#201; mais prov&#225;vel que a hipertrofia conc&#234;ntrica se deva ao fato de 75% dos corredores, com aumento na ERP, serem hipertensos. Vinereanu e cols.<sup>30</sup>, em estudo comparativo de hipertrofia patol&#243;gica e fisiol&#243;gica, demonstraram diferen&#231;a significativa na ERP entre atletas e controles normais (0,46 &#177; 0,06 versus 0,38 &#177; 0,05, p &lt; 0,05, respectivamente), bem como entre atletas, pacientes hipertensos e pacientes com cardiomiopatia hipertr&#243;fica (0,46 &#177; 0,06 versus 0,56 &#177; 0,09 versus 0,72 &#177; 0,13, p &lt; 0,01, respectivamente). Esses resultados demonstram que a ERP na condi&#231;&#227;o patol&#243;gica &#233; muito mais acentuada do que a verificada em atletas. &#201; interessante observar ainda que, embora a an&#225;lise eletrocardiogr&#225;fica tenha apresentado 33% dos atletas com hipertrofia ventricular esquerda, somente 7% tiveram esse diagn&#243;stico confirmado por meio dos valores de &#237;ndice de massa ventricular esquerda &gt; 134 g/m2. Esses resultados sugerem maior sensibilidade, mas baixa especificidade do eletrocardiograma para determinar hipertrofia ventricular em atletas, tornando o ecocardiograma um exame fundamental para uma melhor estratifica&#231;&#227;o das adapta&#231;&#245;es card&#237;acas provocadas pelo treinamento f&#237;sico. De fato, apesar do eletrocardiograma ser considerado padr&#227;o de refer&#234;ncia para o diagn&#243;stico n&#227;o-invasivo de arritmias e dist&#250;rbios de condu&#231;&#227;o, sua especificidade &#233; reduzida para detec&#231;&#227;o de altera&#231;&#245;es estruturais, podendo gerar resultados falso-positivos e superestimar a incid&#234;ncia de hipertrofia ventricular esquerda em atletas.</p>
    <p>Com rela&#231;&#227;o &#224; fun&#231;&#227;o sist&#243;lica ventricular, &#233; conhecido n&#227;o haver modifica&#231;&#227;o desencadeada pelo treinamento f&#237;sico<sup>13,28</sup> de moderada e alta intensidades. No entanto, em tr&#234;s atletas encontramos valores de fra&#231;&#227;o de eje&#231;&#227;o abaixo do limite inferior da normalidade, e constatamos doen&#231;a cardiovascular em dois desses casos. Um atleta era portador de miocardiopatia dilatada de etiologia chag&#225;sica e o outro, de miocardiopatia secund&#225;ria a hipertens&#227;o arterial. &#201; importante refor&#231;armos que nenhum deles conhecia a doen&#231;a at&#233; serem avaliados. Apesar do baixo porcentual de atletas (4%) com fra&#231;&#227;o de eje&#231;&#227;o abaixo do limite inferior de normalidade, esse resultado refor&#231;a a necessidade de avalia&#231;&#227;o cl&#237;nica em atletas, antes da libera&#231;&#227;o para esportes competitivos. A presen&#231;a de disfun&#231;&#227;o ventricular, nesses casos, n&#227;o foi impeditiva para que esses atletas, at&#233; ent&#227;o, demonstrassem bom desempenho f&#237;sico nos treinamentos e competi&#231;&#245;es.</p>
    <p>A diminui&#231;&#227;o da resposta cronotr&#243;pica aos esfor&#231;os mais intensos a partir dos 31 anos sugere menor responsividade beta-adren&#233;rgica com o aumento da idade<sup>31</sup>. Essa altera&#231;&#227;o tem sido explicada pelo preju&#237;zo na sinaliza&#231;&#227;o adren&#233;rgica p&#243;s-receptor com o avan&#231;o da idade<sup>32</sup>. Curioso, no entanto, foi o fato de os atletas apresentarem um maior valor porcentual de freq&#252;&#234;ncia card&#237;aca predita para a idade a partir dos 41 anos. Esses resultados confirmam que a estimativa de freq&#252;&#234;ncia card&#237;aca para a idade baseada na f&#243;rmula 220 &#150; idade19 subestima a freq&#252;&#234;ncia card&#237;aca m&#225;xima absoluta dos corredores com idade superior a 41 anos<sup>33</sup>.</p>
    <p>Apesar da queda significativa do consumo de oxig&#234;nio absoluto no limiar anaer&#243;bio, no grupo de 51 a 60 anos, os valores porcentuais de consumo de oxig&#234;nio s&#227;o mantidos nos corredores mais velhos. Esses resultados sugerem um retardo no in&#237;cio da acidose metab&#243;lica e aumento na efici&#234;ncia oxidativa nesses atletas<sup>16,34-36</sup>. O fato de n&#227;o verificarmos diferen&#231;a significativa no consumo de oxig&#234;nio absoluto, no limiar anaer&#243;bio, nos corredores de 61 a 70 anos, provavelmente se deve ao pequeno n&#250;mero de atletas nessa faixa et&#225;ria. Resultados semelhantes foram verificados no ponto de compensa&#231;&#227;o respirat&#243;ria. A partir de 41 anos, observamos queda no valor absoluto de consumo de oxig&#234;nio, mas uma manuten&#231;&#227;o nos valores porcentuais de consumo de oxig&#234;nio relativo ao pico do esfor&#231;o. Esses resultados s&#227;o evid&#234;ncias adicionais sobre os efeitos do treinamento f&#237;sico na manuten&#231;&#227;o da capacidade oxidativa mesmo com o envelhecimento<sup>16,37</sup>.</p>
    <p>Al&#233;m disso, resultados de estudos anteriores mostram que o treinamento f&#237;sico aer&#243;bico provoca aumento na atividade espec&#237;fica das enzimas oxidativas do m&#250;sculo esquel&#233;tico<sup>38</sup> e maior efic&#225;cia na utiliza&#231;&#227;o de &#225;cidos graxos livres pela betaoxida&#231;&#227;o. Adicionalmente, ele provoca aumento na distribui&#231;&#227;o de fibras musculares oxidativas (Tipo I)<sup>39,40</sup>.</p>
    <p>Nossos corredores n&#227;o apresentaram valores de consumo pico de oxig&#234;nio extremamente elevados, como descrito por outros autores<sup>35,41,42</sup>. Nos estudos anteriores foram avaliados atletas altamente treinados<sup>35</sup> e principalmente corredores de longa dist&#226;ncia (maratonistas)<sup>42</sup>, o que favorece o desenvolvimento de maior capacidade aer&#243;bia. Al&#233;m disso, Fagard e cols.<sup>41</sup> descreveram um volume de treinamento dos corredores que variou de 69 km/semana a 167 km/semana, o que demonstra um n&#237;vel mais elevado de treinamento nesses atletas, comparados aos nossos atletas. Dessa forma, essa diferen&#231;a entre o nosso estudo e outros pode ser explicada pelo per&#237;odo de treinamento f&#237;sico em que nossos atletas se encontravam, pois, possivelmente, nem todos estavam no per&#237;odo competitivo; pelo fato de nossa amostra ser composta por somente 16% de corredores de elite, ou, ainda, por diferen&#231;as gen&#233;ticas<sup>40,43</sup>. Embora ocorra diminui&#231;&#227;o significativa do consumo pico de oxig&#234;nio a partir dos 41 anos de idade, o valor porcentual predito para a idade foi significativamente maior nas faixas et&#225;rias mais elevadas. Isso demonstra que os efeitos do treinamento f&#237;sico na capacidade funcional m&#225;xima s&#227;o independentes da idade<sup>31,44-46</sup>.</p>
    <p><italic>Limita&#231;&#245;es do estudo - </italic>Reconhecemos limita&#231;&#245;es em nosso estudo; dentre elas, que a amostra refere-se aos atletas de um ambulat&#243;rio espec&#237;fico, n&#227;o podendo nossos dados ser extrapolados para outras popula&#231;&#245;es de atletas. Al&#233;m disso, o per&#237;odo de treinamento f&#237;sico dos atletas n&#227;o foi controlado, e os atletas com altera&#231;&#245;es metab&#243;licas ou cardiovasculares n&#227;o foram exclu&#237;dos do estudo. Apesar de reconhecermos que essas condutas possam ter influenciado nossos resultados, nossa inten&#231;&#227;o era descrever a popula&#231;&#227;o de atletas matriculados no Ambulat&#243;rio de Cardiologia do Esporte e Exerc&#237;cio de um hospital terci&#225;rio da cidade de S&#227;o Paulo e, com isso, antecipar para os cardiologistas e profissionais da &#225;rea de sa&#250;de as caracter&#237;sticas de corredores de fundo, que procuram esses ambulat&#243;rios de cardiologia. O n&#250;mero de atletas, por faixa et&#225;ria, ainda &#233; pequeno, mas o suficiente para balizar outros estudos nessa &#225;rea.</p>
    <p><italic>Perspectivas futuras - </italic>Esses resultados, embora preliminares, podem auxiliar cardiologistas quanto aos valores de normalidade da morfologia e funcionamento do cora&#231;&#227;o de corredores de longa dist&#226;ncia, brasileiros, em diferentes faixas et&#225;rias. Al&#233;m disso, podem antecipar os valores de consumo de oxig&#234;nio e freq&#252;&#234;ncia card&#237;aca em diferentes fases do exerc&#237;cio progressivo m&#225;ximo nesses atletas.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflitos de interesses pertinentes.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Luciene Ferreira Azevedo </p>
        <p> Incor - Unidade de Reabilita&#231;&#227;o Cardiovascular e Fisiologia do Exerc&#237;cio </p>
        <p>Av. Dr. En&#233;as C. Aguiar, 44 - Bl. 02 - Andar (-1) </p>
        <p> 05403-000 - S&#227;o Paulo, SP </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="expluciene@incor.usp.br">expluciene@incor.usp.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 02/09/05; revisado recebido em 20/12/05; aceito em 12/01/06.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Stein R, Medeiros CM, Rosito GA, Zimerman    LI, Ribeiro JP. Intrinsic Sinus and atrioventricular node electrophysiologic    adaptations in endurance athletes. J Am Coll Cardiol. 2002; 39:1033-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Intrinsic Sinus and atrioventricular node electrophysiologic adaptations in endurance athletes</article-title>
          <source>J Am Coll Cardiol.</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1033</fpage>
          <lpage>8</lpage>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Medeiros</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Rosito</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Zimerman</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Chapman JH. Profound sinus bradycardia in    the athletic heart syndrome. J Sports Med Phys Fitness. 1982; 22: 45-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Profound sinus bradycardia in the athletic heart syndrome</article-title>
          <source>J Sports Med Phys Fitness.</source>
          <date>
            <year>1982</year>
          </date>
          <fpage>45</fpage>
          <lpage>8</lpage>
          <volume>22</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chapman</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Pluim BM, Zwinderman AH, Laarse A van der,    Wall EE van der. The Athlete's Heart. A meta-analysis of cardiac structure and    function. Circulation. 1999; 100: 336-44.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The Athlete's Heart: A meta-analysis of cardiac structure and function</article-title>
          <source>Circulation.</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>336</fpage>
          <lpage>44</lpage>
          <volume>100</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pluim</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Zwinderman</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Laarse</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>van der, Wall</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>van der</surname>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Corrado D, Pelliccia A, Bjornstad HH, Vanhess    L, Biffi A, Borjesson M et al. Cardiovascular pre-participation screening of    young competitive athletes for prevention of sudden death: proposal for a common    European protocol. Consensus Statement of the Study Group of Sport Cardiology    of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the    Working Group of Myocardial and Pericardial Diseases of the European Society    of Cardiology. Eur Heart J. 2005; 26: 516-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology</article-title>
          <source>Eur Heart J.</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>516</fpage>
          <lpage>24</lpage>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Corrado</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pelliccia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bjornstad</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Vanhess</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Biffi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Borjesson</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Van Camp SP, Bloor CM, Mueller FO, Cantu RC,    Olson HG. Nontraumatic sports death in high school and college athletes. Med    Sci Sports Exerc. 1995; 27: 641-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nontraumatic sports death in high school and college athletes</article-title>
          <source>Med Sci Sports Exerc.</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>641</fpage>
          <lpage>7</lpage>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Van Camp</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Bloor</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>FO</given-names>
            </name>
            <name>
              <surname>Cantu</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>HG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Maron BJ, Shirani J, Poliac LC, Mathenge R,    Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical,    demographic, and pathological profiles. JAMA. 1996; 276: 199-204.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sudden death in young competitive athletes: Clinical, demographic, and pathological profiles</article-title>
          <source>JAMA.</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>199</fpage>
          <lpage>204</lpage>
          <volume>276</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Maron</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Shirani</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Poliac</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Mathenge</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>FO.</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Maron BJ. Sudden death in young athletes.    N Engl J Med. 2003; 349: 1064-75.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sudden death in young athletes</article-title>
          <source>N Engl J Med.</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1064</fpage>
          <lpage>75</lpage>
          <volume>349</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Maron</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Lorvidhaya P, Stephen Huang SK. Sudden cardiac    death in athletes. Cardiology. 2003; 100: 186-95.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sudden cardiac death in athletes</article-title>
          <source>Cardiology.</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>186</fpage>
          <lpage>95</lpage>
          <volume>100</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lorvidhaya</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Stephen Huang</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Sokolow M, Lyon TP. The ventricular complex    in left ventricular hypertrophy as obtained by unipolar precordial and limb    leads. Ann Noninvasive Electrocardiol. 2001; 6: 343-68.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads</article-title>
          <source>Ann Noninvasive Electrocardiol.</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>343</fpage>
          <lpage>68</lpage>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sokolow</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lyon</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Gardin JM, Adams DB, Douglas PS, Feigenbaum    H, Fort DH, Fraser AG et al. American Society of Echocardiography. Recommendations    for a standardized report for adult transthoracic echocardiography: a report    from the American Society of Echocardiographys Nomenclature and Standards Committee    and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr.    2002; 15: 275-90.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>American Society of Echocardiography: Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography&#8217;s Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report</article-title>
          <source>J Am Soc Echocardiogr.</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>275</fpage>
          <lpage>90</lpage>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gardin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Douglas</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Feigenbaum</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fort</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Fraser</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Devereux RB, Liebson PR, Horan MJ. Recommendations    concern the use of echocardiography in hypertension and general population research.    Hypertension. 1987; 9: 97-104.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Recommendations concern the use of echocardiography in hypertension and general population research</article-title>
          <source>Hypertension.</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>97</fpage>
          <lpage>104</lpage>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Devereux</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Liebson</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Horan</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Douglas OS, OToole MI, Katz SE, Ginsburg    GS, Hiller WD, Laird RH. Left ventricular hypertrophy in athletes. Am J Cardiol.    1997; 80: 1384-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Left ventricular hypertrophy in athletes</article-title>
          <source>Am J Cardiol.</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1384</fpage>
          <lpage>8</lpage>
          <volume>80</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Douglas</surname>
              <given-names>OS</given-names>
            </name>
            <name>
              <surname>O&#8217;Toole</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Hiller</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Laird</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Pelliccia A, Culasso F, Di Paolo FM, Maron    BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern    Med. 1999; 130: 23-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Physiologic left ventricular cavity dilatation in elite athletes</article-title>
          <source>Ann Intern Med.</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>23</fpage>
          <lpage>31</lpage>
          <volume>130</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pelliccia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Culasso</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Di Paolo</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Maron</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Henry WL, Gardin JM, Ware JH. Echocardiographic    measurements in normal subjects from infancy to old age. Circulation. 1980;    62: 1054-61.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Echocardiographic measurements in normal subjects from infancy to old age</article-title>
          <source>Circulation.</source>
          <date>
            <year>1980</year>
          </date>
          <fpage>1054</fpage>
          <lpage>61</lpage>
          <volume>62</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Henry</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Gardin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ware</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Buchfuhrer MJ, Hansen JE, Robinson TE, Sue    DY, Wasserman K, Whipp BJ. Optimizing the exercise protocol for cardiopulmonary    assessment. J Appl Physiol. 1983; 55: 1558-64.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Optimizing the exercise protocol for cardiopulmonary assessment</article-title>
          <source>J Appl Physiol.</source>
          <date>
            <year>1983</year>
          </date>
          <fpage>1558</fpage>
          <lpage>64</lpage>
          <volume>55</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Buchfuhrer</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Sue</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Wasserman</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Whipp</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Skinner JS, McLellan TH. The transition from    aerobic to anaerobic metabolism. Res Q Exerc Sport.1980; 51: 234-48.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The transition from aerobic to anaerobic metabolism</article-title>
          <source>Res Q Exerc Sport.</source>
          <date>
            <year>1980</year>
          </date>
          <fpage>234</fpage>
          <lpage>48</lpage>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Skinner</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>McLellan</surname>
              <given-names>TH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Abergel E, Chatellier G, Hagege AA, Oblak    A, Linhart A, Ducardonnet A et al. Serial Left Ventricular Adaptations in World-    Class Professional Cyclists. J Am Coll Cardiol. 2004, 44: 144-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Serial Left Ventricular Adaptations in World- Class Professional Cyclists</article-title>
          <source>J Am Coll Cardiol.</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>144</fpage>
          <lpage>9</lpage>
          <volume>44</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Abergel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chatellier</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hagege</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Oblak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Linhart</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ducardonnet</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Devereux RB, Lutas EM, Casale PN, Kligfield    P, Eisenberg RR, Hammond JW et al Standardization of M-mode echocardiographic    left ventricular anatomic measurements. J Am Coll Cardiol. 1984; 4: 1222-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Standardization of M-mode echocardiographic left ventricular anatomic measurements</article-title>
          <source>J Am Coll Cardiol.</source>
          <date>
            <year>1984</year>
          </date>
          <fpage>1222</fpage>
          <lpage>30</lpage>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Devereux</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Lutas</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Casale</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Kligfield</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Eisenberg</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Hammond</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Fox SM, Naughton JP, Haskell WL. Physical    activity and the prevention of coronary heart disease. Ann Clin Res. 1971; 3:    404-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Physical activity and the prevention of coronary heart disease</article-title>
          <source>Ann Clin Res.</source>
          <date>
            <year>1971</year>
          </date>
          <fpage>404</fpage>
          <lpage>32</lpage>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fox</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Naughton</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Haskell</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Zehender M, Meinertz T, Keul J, Just H. ECG    variants and cardiac arrhythmias in athletes: Clinical relevance and prognostic    importance. Am Heart J. 1990; 119: 1378-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>ECG variants and cardiac arrhythmias in athletes: Clinical relevance and prognostic importance</article-title>
          <source>Am Heart J.</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>1378</fpage>
          <lpage>91</lpage>
          <volume>119</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Zehender</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meinertz</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Keul</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Just</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Maron BJ, Mitchell JH. Revised eligibility    recommendations for competitive athletes with cardiovascular abnormalities.    J Am Coll Cardiol. 1994; 24: 848-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities</article-title>
          <source>J Am Coll Cardiol.</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>848</fpage>
          <lpage>50</lpage>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Maron</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Furlan R, Piazza S, DellOrto S, Gentile    E, Cerutti S, Pagani M et al. Early and late effects of exercise and athletic    training on neural mechanisms controlling heart rate. Cardiovasc Res. 1993;    27: 482-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Early and late effects of exercise and athletic training on neural mechanisms controlling heart rate</article-title>
          <source>Cardiovasc Res.</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>482</fpage>
          <lpage>8</lpage>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Furlan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Piazza</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dell&#8217;Orto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gentile</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cerutti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pagani</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Pichot V, Roche F, Gaspoz JM, Enjobras F,    Antoniadis A, Minini P et al. Relation between heart rate variability and training    load in middle-distance runners. Med Sci Sports Exerc. 2000; 32: 1729-36.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relation between heart rate variability and training load in middle-distance runners</article-title>
          <source>Med Sci Sports Exerc.</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1729</fpage>
          <lpage>36</lpage>
          <volume>32</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pichot</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Roche</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gaspoz</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Enjobras</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Antoniadis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Minini</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Iellamo F, Legramante JM, Pigozzi F, Spataro    A, Norbiato G, Lucini D et al. Conversion from vagal to sympathetic predominance    with strenuous training in high-performance world class athletes. Circulation.    2002; 105: 2719-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Conversion from vagal to sympathetic predominance with strenuous training in high-performance world class athletes</article-title>
          <source>Circulation.</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>2719</fpage>
          <lpage>24</lpage>
          <volume>105</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Iellamo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Legramante</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Pigozzi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Spataro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Norbiato</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lucini</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Allen WR. A athlete and heart disease: diagnosis,    evaluation &amp; management. Philadelphia: Lippincott Williams &amp; Wilkins;    1999.</mixed-citation>
        <element-citation publication-type="book">
          <source>A athlete and heart disease: diagnosis, evaluation &amp; management</source>
          <date>
            <year>1999</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Allen</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Fagard RH. Athletes heart: a meta-analysis    of the echocardiographic experience. Int. J. Sports Med. 1996; 17: S140-S144.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Athlete&#8217;s heart: a meta-analysis of the echocardiographic experience</article-title>
          <source>Int. J. Sports Med.</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>S140</fpage>
          <lpage>S144</lpage>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fagard</surname>
              <given-names>RH.</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Hoogsteen J, Hoogeveen A, Schaffers H, Wijn    PF, van Hemel NM, van der Wall EE. Myocardial adaptation in different endurance    sports: an echocardiographic study. Int J Cardiovasc Imaging. 2004; 20: 19-26.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial adaptation in different endurance sports: an echocardiographic study</article-title>
          <source>Int J Cardiovasc Imaging.</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>19</fpage>
          <lpage>26</lpage>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hoogsteen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hoogeveen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schaffers</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wijn</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>van Hemel</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>van der Wall</surname>
              <given-names>EE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Pelliccia A, Culasso F, Di Paolo FM, Maron    BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern    Med. 1999; 130: 23-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Physiologic left ventricular cavity dilatation in elite athletes</article-title>
          <source>Ann Intern Med.</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>23</fpage>
          <lpage>31</lpage>
          <volume>130</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pelliccia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Culasso</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Di Paolo</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Maron</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Hernandez D, de la Rosa A, Barragan A, Barrios    Y, Salido E, Torres A et al. The ACE/DD genotype is associated with the extent    of exercise-induced left ventricular growth in endurance athletes. J Am Coll    Cardiol. 2003; 42: 527-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes</article-title>
          <source>J Am Coll Cardiol.</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>527</fpage>
          <lpage>32</lpage>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hernandez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>de la Rosa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barragan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barrios</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Salido</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Vinereanu D, Florescu N, Sculthorpe N, Tweddel    AC, Stephens MR, Fraser AG. Differentiation between pathologic and physiologic    left ventricular hypertrophy by tissue Doppler assessment of long-axis function    in patients with hypertrophic cardiomyopathy or systemic hypertension and in    athletes. Am J Cardiol. 2001; 88: 53-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes</article-title>
          <source>Am J Cardiol.</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>53</fpage>
          <lpage>8</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Vinereanu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Florescu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sculthorpe</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tweddel</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Stephens</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Fraser</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Seals DR, Taylor JA, Ng AV, Esler MD. Exercise    and aging: autonomic control of the circulation. Med Sci Sports Exerc. 1994;    26: 568-76.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise and aging: autonomic control of the circulation</article-title>
          <source>Med Sci Sports Exerc.</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>568</fpage>
          <lpage>76</lpage>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Seals</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Esler</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Roth DA, White CD, Podolin DA, Mazzeo RS.    Alterations in myocardial signal transduction due to aging and chronic dynamic    exercise. J Appl Physiol. 1998; 84: 177-84.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Alterations in myocardial signal transduction due to aging and chronic dynamic exercise</article-title>
          <source>J Appl Physiol.</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>177</fpage>
          <lpage>84</lpage>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Roth</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Podolin</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Mazzeo</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Tanaka H, Monahan KD, Seals DR. Age-predicted    maximal heart rate revisited. J Am Coll Cardiol. 2001; 37: 153-6</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Age-predicted maximal heart rate revisited</article-title>
          <source>J Am Coll Cardiol.</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>153</fpage>
          <lpage>6</lpage>
          <volume>37</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Monahan</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Seals</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Simon J, Young JL, Blood DK, Segal KR, Case    RB, Gutin B. Plasma lactate and ventilation thresholds in trained and untrained    cyclists. J Appl Physiol. 1986; 60: 777-81.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Plasma lactate and ventilation thresholds in trained and untrained cyclists</article-title>
          <source>J Appl Physiol.</source>
          <date>
            <year>1986</year>
          </date>
          <fpage>777</fpage>
          <lpage>81</lpage>
          <volume>60</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Simon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Blood</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Segal</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Case</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Gutin</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Bunc V, Heller J, Leso J, Sprynarova S, Zdanowicz    R. Ventilatory threshold in various groups of highly trained athletes. Int J    Sports Med. 1987; 8: 275-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ventilatory threshold in various groups of highly trained athletes</article-title>
          <source>Int J Sports Med.</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>275</fpage>
          <lpage>80</lpage>
          <volume>8</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bunc</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Heller</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Leso</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sprynarova</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zdanowicz</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Yoshida T, Suda Y, Takeuchi N. Endurance    training regimen based upon arterial blood lactate: effects on anaerobic threshold.    Eur J Appl Physiol Occup Physiol. 1982; 49: 223-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Endurance training regimen based upon arterial blood lactate: effects on anaerobic threshold</article-title>
          <source>Eur J Appl Physiol Occup Physiol.</source>
          <date>
            <year>1982</year>
          </date>
          <fpage>223</fpage>
          <lpage>30</lpage>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yoshida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Costill DL. Metabolic responses during distance    running. J Appl Physiol. 1970; 28: 251-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Metabolic responses during distance running</article-title>
          <source>J Appl Physiol.</source>
          <date>
            <year>1970</year>
          </date>
          <fpage>251</fpage>
          <lpage>5</lpage>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Costill</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Rusko H, Rahkila P, Karvinen E. Anaerobic    threshold, skeletal muscle enzymes and fiber composition in young female cross-country    skiers. Acta Physiol Scand. 1980; 108: 263-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Anaerobic threshold, skeletal muscle enzymes and fiber composition in young female cross-country skiers</article-title>
          <source>Acta Physiol Scand.</source>
          <date>
            <year>1980</year>
          </date>
          <fpage>263</fpage>
          <lpage>8</lpage>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rusko</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rahkila</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Karvinen</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39. Flynn MG, Costill DL, Kirwan JP, Fink WJ,    Dengel DR. Muscle fiber composition and respiratory capacity in triathletes.    Int J Sports Med. 1987; 8: 383-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Muscle fiber composition and respiratory capacity in triathletes</article-title>
          <source>Int J Sports Med.</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>383</fpage>
          <lpage>6</lpage>
          <volume>8</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Flynn</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Costill</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Kirwan</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Dengel</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B40">
        <mixed-citation>40. Hamel P, Simoneau JA, Lortie G, Boulay MR,    Bouchard C. Heredity and muscle adaptation to endurance training. Med Sci Sports    Exerc. 1986; 18: 690-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Heredity and muscle adaptation to endurance training</article-title>
          <source>Med Sci Sports Exerc.</source>
          <date>
            <year>1986</year>
          </date>
          <fpage>690</fpage>
          <lpage>6</lpage>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hamel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Simoneau</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Lortie</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Boulay</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Bouchard</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B41">
        <mixed-citation>41. Fagard R, Aubert A, Staessen J, Eynde EV,    Vanhees L, Amery A. Cardiac structure and function in cyclists and runners.    Comparative echocardiographic study. Br Heart J. 1984; 52: 124-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac structure and function in cyclists and runners: Comparative echocardiographic study</article-title>
          <source>Br Heart J.</source>
          <date>
            <year>1984</year>
          </date>
          <fpage>124</fpage>
          <lpage>9</lpage>
          <volume>52</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fagard</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Aubert</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Staessen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Eynde</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Vanhees</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Amery</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B42">
        <mixed-citation>42. Paulsen W, Boughner DR, Ko P, Cunningham    DA, Persaud JA. Left ventricular function in marathon runners: echocardiographic    assessment. J Appl Physiol. 1981; 51: 881-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Left ventricular function in marathon runners: echocardiographic assessment</article-title>
          <source>J Appl Physiol.</source>
          <date>
            <year>1981</year>
          </date>
          <fpage>881</fpage>
          <lpage>6</lpage>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Paulsen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Boughner</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cunningham</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Persaud</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B43">
        <mixed-citation>43. Skinner JS, Jask&#243;lski A, Jask&#243;lska    A, Krasnoff J, Gagnon J, Leon AS et al. Age, sex, race, initial fitness, and    response to training: the HERITAGE Family Study. J Appl Physiol. 2001; 90: 1770-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Age, sex, race, initial fitness, and response to training: the HERITAGE Family Study</article-title>
          <source>J Appl Physiol.</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1770</fpage>
          <lpage>6</lpage>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Skinner</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Jask&#243;lski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jask&#243;lska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Krasnoff</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gagnon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Leon</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B44">
        <mixed-citation>44. Kasch FW, Boyer JL, Schmidt PK, Wells RH,    Wallace JP, Verity LS et al. Ageing of the cardiovascular system during 33 years    of aerobic exercise. Age Ageing. 1999; 28: 531-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ageing of the cardiovascular system during 33 years of aerobic exercise</article-title>
          <source>Age Ageing.</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>531</fpage>
          <lpage>6</lpage>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kasch</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Boyer</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Verity</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B45">
        <mixed-citation>45. Jackson AS, Wier LT, Ayers GW, Beard EF,    Stuteville JE, Blair SN. Changes in aerobic power of women, ages 20-64yr. Med    Sci Sports Exerc. 1996; 28: 884-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Changes in aerobic power of women, ages 20-64yr</article-title>
          <source>Med Sci Sports Exerc.</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>884</fpage>
          <lpage>91</lpage>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jackson</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Wier</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Ayers</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Beard</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Stuteville</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Blair</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B46">
        <mixed-citation>46. Wiebe CG, Gledhill N, Jamnik VK, Ferguson    S. Exercise cardiac function in young through elderly endurance trained women.    Med Sci Sports Exerc. 1999; 31: 684-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise cardiac function in young through elderly endurance trained women</article-title>
          <source>Med Sci Sports Exerc.</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>684</fpage>
          <lpage>91</lpage>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wiebe</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Gledhill</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jamnik</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>Ferguson</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Cardiac and metabolic characteristics in long distance runners of sport and exercise cardiology outpatient facility of a tertiary hospital</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>OBJECTIVE: To characterize electrocardiographic and functional cardiac parameters and cardiopulmonary responses to exercise in long-distance Brazilian runners monitored at the Sport and Exercise Cardiology Outpatient Facility of a tertiary care hospital. METHODS: Of an initial population of 443 male and female athletes of different sport modalities, we assessed 162 (37%) long-distance male runners, aged from 14 to 67. Electrocardiographic (12 leads) and echocardiographic (M-mode and two-dimensional) parameters were recorded at rest. Cardiopulmonary responses were evaluated on a treadmill with a ramp protocol. RESULTS: Metabolic alterations and cardiovascular diseases were diagnosed in 17% and 9% of the runners, respectively. Sinus bradycardia and left ventricular hypertrophy were observed in 62% and 33% of the runners, respectively. Structural alterations such as ventricular cavity &gt; 55mm, relative wall thickness &gt; 0.44, and ventricular mass index &gt; 134g/m2 were found in 15%, 11% and 7% of the runners, respectively. Ejection fraction &lt; 55% was observed in 4% of the runners. Peak oxygen uptake (VO2peak) decreased as of the age of 41, although the anaerobic threshold relative to the VO2peak remained unchanged with age. CONCLUSION: Resting bradycardia and left ventricular hypertrophy are the most frequent cardiovascular adaptations in Brazilian long distance runners monitored by the Sport and Exercise Cardiology Outpatient Facility. Although VO2peak decreases after the age of 41, the relative oxygen uptake at the anaerobic threshold of these runners remained unchanged.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Electrocardiography</kwd>
        <kwd>heart rate</kwd>
        <kwd>hypertrophy</kwd>
        <kwd>left ventricular</kwd>
        <kwd>oxygen consumption</kwd>
        <kwd>anaerobic threshold</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>Cardiac and metabolic characteristics of long distance runners of the sport and exercise cardiology outpatient Facility of a tertiary hospital</p>
      <p>
        <bold>Luciene Ferreira Azevedo; Patr&#237;cia Chakur Brum; Dudley Rosemblatt; Patr&#237;cia de S&#225; Perlingeiro; Ant&#244;nio Carlos Pereira Barretto; Carlos Eduardo Negr&#227;o; Luciana Diniz Nagem Janot de Matos</bold>
      </p>
      <p> Instituto do Cora&#231;&#227;o do Hospital das Cl&#237;nicas &#150; FMUSP and Escola de Educa&#231;&#227;o F&#237;sica e Esporte da Universidade de S&#227;o Paulo - S&#227;o Paulo, SP, Brazil</p>
      <p>
        <xref ref-type="corresp" rid="end-body2">Mailing Address</xref>
      </p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>OBJECTIVE: </bold>To characterize electrocardiographic and functional cardiac parameters and cardiopulmonary responses to exercise in long-distance Brazilian runners monitored at the Sport and Exercise Cardiology Outpatient Facility of a tertiary care hospital.</p>
      <p><bold>METHODS:</bold> Of an initial population of 443 male and female athletes of different sport modalities, we assessed 162 (37%) long-distance male runners, aged from 14 to 67. Electrocardiographic (12 leads) and echocardiographic (M-mode and two-dimensional) parameters were recorded at rest. Cardiopulmonary responses were evaluated on a treadmill with a ramp protocol. </p>
      <p><bold>RESULTS:</bold> Metabolic alterations and cardiovascular diseases were diagnosed in 17% and 9% of the runners, respectively. Sinus bradycardia and left ventricular hypertrophy were observed in 62% and 33% of the runners, respectively. Structural alterations such as ventricular cavity &gt; 55mm, relative wall thickness &gt; 0.44, and ventricular mass index &gt; 134g/m2 were found in 15%, 11% and 7% of the runners, respectively. Ejection fraction &lt; 55% was observed in 4% of the runners. Peak oxygen uptake (VO2peak) decreased as of the age of 41, although the anaerobic threshold relative to the VO2peak remained unchanged with age.</p>
      <p><bold>CONCLUSION:</bold> Resting bradycardia and left ventricular hypertrophy are the most frequent cardiovascular adaptations in Brazilian long distance runners monitored by the Sport and Exercise Cardiology Outpatient Facility. Although VO2peak decreases after the age of 41, the relative oxygen uptake at the anaerobic threshold of these runners remained unchanged.</p>
      <p><bold>Key words:</bold> Electrocardiography, heart rate, hypertrophy, left ventricular, oxygen consumption, anaerobic threshold.</p>
      <p>Intense physical training carried out by athletes to improve their performance in sports exposes the heart to intense overload in the course of months or years. This frequent exposure to overload results in alterations in heart automaticity, such as bradycardia at rest, and alterations in atrioventricular conduction, ventricular depolarization and repolarization1,2. Structural adjustments of the heart are also considerable and may lead to increases of up to 85% in the mass of the left ventricle3. Despite the fact that these functional and structural alterations have been duly documented, their limits of normality and their long-term consequences remain unknown. </p>
      <p>The clinical and cardiological assessment of athletes is a very important medical procedure that enables: A) the identification of the degree of cardiac alterations as a result of intense physical training and B) the diagnosis of pre-existing heart diseases4. Ruling out pre-existing heart diseases is paramount to prevent fatal events in athletes. Although the risk of sudden death in athletes is low (one death per three hundred thousand athletes per year)5,6, the presence of a hidden cardiovascular disease increases one-hundred fold the risk of a fatal cardiac event. Therefore, being able to differentiate alterations triggered by physical training from pre-existing pathological alterations is the first challenge for sport cardiology practitioners4.</p>
      <p>In Brazil, data on the health conditions and on the characteristics of the cardiovascular systems of athletes are scarce. Adding to this is the lack of statistics on the most frequent conditions and on the rate of sudden death for these athletes. In the United States, hypertrophic cardiomyopathy ranks first among the conditions that account for the sudden death of athletes, whereas in Italy, arrhythmogenic right ventricle dysplasia7,8 is the most frequently found condition. These results evidence the fact that cardiovascular characteristics of high level athletes may vary across countries.</p>
      <p>In an attempt to broaden our knowledge on the cardiovascular characteristics of Brazilian athletes, this study aimed at characterizing: 1) the structure and functioning of the heart of Brazilian long-distance runners, registered at the Sport and Exercise Cardiology Outpatient Facility of a tertiary hospital in the City of S&#227;o Paulo; and 2) the cardiopulmonary capacity and the metabolic profile during maximum progressive physical exercise in these athletes.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>Of the records of 443 athletes (342 men and 101 women) registered at the Sport and Exercise Cardiology Outpatient Facility of a tertiary hospital of the City of S&#227;o Paulo, Brazil, distributed in nineteen sport modalities as presented in <xref ref-type="fig" rid="fig01-body2">figure 1</xref>, we selected 162 long distance male runners (&gt; 3,000 m), with ages between fourteen and 67 years. The athletes&#146; mean time of training for competition was 11.2 &#177; 0.7 years. They had from three to seven training sessions per week, with a volume that varied from 30 to 160 km per week, with moderate (heart rates between the anaerobic threshold and the respiratory compensation point) and high intensity (heart rate above the respiratory compensation point). Most athletes included in the study were amateurs.</p>
      <fig id="fig01-body2">
        <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gf01-en.jpg"/></fig>
      <p>Electrocardiographic assessment - The electrocardiogram was performed in the supine position, after five minutes at rest, with twelve standard leads, speed of 25 mm/s and voltage of 10 mm/mV (Hewlett Packard, HP 708), as part of the routine examination for registration at the Sport and Exercise Cardiology Outpatient Facility. Sinus bradycardia at rest was defined in two heart rate ranges: &lt; 60bpm and &lt; 50bpm. We used the Sokolow-Lyon<sup>9</sup> index to verify left ventricle hypertrophy.</p>
      <p>Morphological and functional assessment of the heart - The morphology and function of the left ventricle were assessed on two-dimensional echocardiogram (Sonos 5500, Hewlett Packard, Massachusetts, USA). Left ventricular cavity diameters were obtained on the M-mode, guided by the two-dimensional mode, according to the guidelines of the American Society of Echocardiography<sup>10</sup>. Left ventricular mass was calculated with the Cube formula11: 0.8[1.04(LVDD + PWT + IVST)3 &#150; LVDD3] + 0.6g, and was expressed as a ratio of the body surface area (left ventricular mass index, g/m2). The relative wall thickness (RWT) was calculated as: (ventricular septum + posterior wall)/left ventricular diastolic diameter, with a distinction between eccentric (RWT &lt; 0.44) and concentric hypertrophy (RWT <underline>&gt;</underline> 0.44). Ventricular volumes were calculated using Teichholz&#146;s formula: [7/(2.4 + LVDD) x LVDD3] and were used to calculate left ventricular ejection fraction (LVEF - %). Left ventricular hypertrophy was defined as ventricular septum and/or left ventricle posterior wall values &gt;13 mm and left ventricular mass index &gt; 134g/m2. Abnormal dilatation of the left ventricular cavity was defined as left ventricular diastolic diameter (LVDD) &gt; 60 mm<sup>12-14</sup>.</p>
      <p>Cardiopulmonary functional analysis - The assessment of maximum functional capacity of athletes was carried out by employing a cardiopulmonary test on a treadmill (Quinton Q65, model 645, Quinton Instruments Co., Washington, USA), with a ramp protocol until exhaustion. Load increments were added every minute and defined according to the physical capacity of each athlete, so that the total exercise time varied between eight and seventeen minutes, as previously described<sup>15</sup>. The athletes were advised as to the diet prior to the test and were told not to exercise within 24 hours prior to the test. </p>
      <p>Oxygen uptake (VO2) and the production of carbon dioxide (VCO2) were determined through the mean of respiratory gas exchange by using a computerized system (Vmax, series 229 - SensorMedics Corporation, California, USA). Peak oxygen uptake (VO2peak) was defined as the maximum VO2 measured at the end of the exercise bout, when the athlete was no longer able to maintain the load imposed by the ergometer. The anaerobic threshold was determined by the loss of linearity between VCO2 and VO2, the point where the ventilatory equivalent of oxygen (VE/VO2) or the end-tidal oxygen pressure (PetO2) reached its lowest level before starting to increase during the test. The respiratory compensation point was determined at the point where the ventilatory equivalent of carbon dioxide (VE/VCO2) reached its lowest level before starting to increase and where the end-tidal carbon dioxide pressure (PetCO2) reached its maximum value before decreasing<sup>16</sup>.</p>
      <p>Heart rate was monitored throughout the test using a 12-lead electrocardiogram (Marquette Medical Systems, InC. CardioSoft, Wisconsin, USA). The blood pressure was measured using a mercury-column sphygmomanometer before the beginning of the test and during the exercise bout.</p>
      <p>Statistical analysis - The data are presented as mean &#177; standard error of mean. In order to identify the possible differences between age groups we used the one-way analysis of variance (one-way ANOVA &#150; Statistica Software), followed by Scheff&#233;&#146;s post hoc test. We adopted p &lt; 0.05 for statistical significance.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Clinical and cardiological parameters - Of the 162 runners assessed, 27 (17%) presented metabolic alterations (six had iron deficiency anemia; one had hypothyroidism; seventeen had dyslipidemia; three had elevated glycemia) and fifteen (9%) presented cardiovascular diseases (thirteen had systemic arterial hypertension and two had Chagas disease, with one athlete having its undetermined form and the other having myocardiopathy). Only the athlete with Chagas&#146; myocardiopathy was excluded from the sample and declared unfit for the practice of competitive sports.</p>
      <p>Physical and hemodynamic characteristics of the different age groups at rest are presented in <xref ref-type="table" rid="tab01-body2">Table 1</xref>. The percentage distribution of athletes across the different age groups was as follows: until 30 years (26%), 31 to 40 years (32%), 41 to 50 years (24%), 51 to 60 years (14%) and 61 to 70 years (4%). The group aged up to 30 years presented a body mass index (BMI) significantly lower that the other groups from 31 to 40 years, 41 to 50 years, 51 to 60 years, and 61 to 70 years (21 &#177; 0.3 versus 22 &#177; 0.3; 23 &#177; 0.4; 24 &#177; 0.5; 24 &#177; 1,0; p = 0,0001), respectively. Systolic and diastolic arterial pressure and heart rate values were not different across athletes of different age groups. We verified that 86% of the athletes presented heart rate &lt; 60 bpm (mean of 49 &#177; 0.5 bpm), but when we consider heart rates &lt; 50 bpm (mean of 44 &#177; 0.1 bpm), this percentage decreases to 62%. Left ventricular hypertrophy was verified in 33% of the runners and early repolarization was observed in 20% (<xref ref-type="fig" rid="fig02-body2">fig. 2</xref>). The prevalence of these alterations remained unchanged when the electrocardiogram analysis was carried out per age group (<xref ref-type="fig" rid="fig03-body2">fig. 3</xref>).</p>
      <table-wrap id="tab01-body2">
        <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gt01-en.jpg"/></table-wrap>
      <fig id="fig02-body2">
        <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gf02-en.jpg"/></fig>
      <fig id="fig03-body2">
        <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gf03-en.jpg"/></fig>
      <p>Echocardiographic parameters did not show significant differences across groups of runners on different age groups, with the exception of relative wall thickness (RWT), which was significantly higher in the 51 to 60 age group, as compared with the aged up to -30 group (0.41 &#177; 0.02 versus 0.36 &#177; 0.01; p = 0.04) (<xref ref-type="table" rid="tab02-body2">table. 2</xref>). Eight long-distance runners (11%) presented relative wall thickness values (RWT) <underline>&gt;</underline> 0.44, characterizing a concentric hypertrophy pattern17. Of these eight runners, six (75%) were hypertensive. </p>
      <table-wrap id="tab02-body2">
        <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gt02-en.jpg"/></table-wrap>
      <p>In 64 athletes (85%), the size of the cavity of the left ventricle (left ventricular diastolic diameter) was within normal values (<underline>&lt;</underline> 54 mm). However, eleven long-distance runners (15%) presented values above the upper normal limit (<underline>&gt;</underline> 55 mm)14,17. The highest measures of ventricular septum and posterior wall of the left ventricle did not exceed the upper normal limit (13 mm)14. As regards the left ventricular mass index, five long-distance runners (7%) exceeded the normal limit (&gt; 134 g/m2)18. Left ventricular ejection fraction was below the normal limit (&lt; 55%)14,18 in only three athletes (4%), of whom one was in the 31 to 40 age group, one was in the 51 to 60 age group and one was in the 61 to 70 age group.</p>
      <p>Cardiovascular and metabolic parameters during cardiopulmonary functional assessment - The values of heart rate and oxygen uptake at the anaerobic threshold, at the respiratory compensation point and at peak exertion for the different age groups are shown on <xref ref-type="table" rid="tab03-body2">Tables 3</xref> and <xref ref-type="table" rid="tab04-body2">4</xref>, respectively. Heart rates at the anaerobic threshold for the different age groups were similar in terms of absolute values (147 &#177; 2; 142 &#177; 2; 137 &#177; 3; 140 &#177; 3; 131 &#177; 6, p &gt; 0.05) as well as in terms of relative values (percentage of peak heart rate). Absolute heart rate at the respiratory compensation point was significantly lower in the age groups from 31 to 40 years, 41 to 50 years, 51 to 60 years, and 61 to 70 years, as compared with the group aged up to 30 years (167 &#177; 2; 165 &#177; 2; 161 &#177; 3; 158 &#177; 5 versus 175 &#177; 2; p &lt; 0.05), respectively. However, when the heart rate was expressed relative to the percentage of peak heart rate, no significant difference was observed across age groups. Peak heart rate decreased significantly in the groups from 31 to 40 years, 41 to 50 years, 51 to 60 years, and 61 to 70 years, as compared with the group aged up to 30 years (176 &#177; 1; 175 &#177; 2; 171 &#177; 3; 167 &#177; 5 versus 184 &#177; 2; p &lt; 0.05), respectively. When peak heart rate was presented as a percentage value of the maximum heart rate predicted for their age19, athletes of the groups from 41 to 50 years, 51 to 60 years and 61 to 70 years presented significantly higher values than the group aged up to 30 years and the group from 31 to 40 years (100 &#177; 1; 103 &#177; 1; 103 &#177; 3 versus 94 &#177; 1 and 95 &#177; 1; p &lt; 0.05), respectively.</p>
      <table-wrap id="tab03-body2">
        <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gt03-en.jpg"/></table-wrap>
      <table-wrap id="tab04-body2">
        <graphic xlink:href="1678-4170-abc-88-01-0017-00003-gt04-en.jpg"/></table-wrap>
      <p>Absolute oxygen consumption at the anaerobic threshold was significantly lower in the group from 51 to 60 years as compared with the group aged up to 30 years (33 &#177; 1 versus 40 &#177; 1; p &lt; 0.05). However, when oxygen consumption was expressed relative to peak oxygen consumption, this difference was no longer observed. Absolute oxygen consumption at the respiratory compensation point decreased significantly in the groups from 41 to 50 years, 51 to 60 years and 61 to 70 years as compared with the group aged up to 30 years (46 &#177; 1; 44 &#177; 1; 42 &#177; 3 versus 54 &#177; 1; p &lt; 0.05), respectively. However, when these values were expressed relative to peak oxygen consumption, these differences were no longer observed. Peak oxygen consumption decreased significantly in the groups from 41 to 50 years, 51 to 60 years and 61 to 70 years as compared with the group aged up to 30 years (52 &#177; 0.2; 48 &#177; 0.4; 46 &#177; 1.1 versus 60 &#177; 0.2; p &lt; 0.05), respectively. However, athletes aged from 41 to 50 reached maximum oxygen consumption values predicted for their age which were significantly higher than those of athletes aged up to 30 years (150 &#177; 1 versus 128 &#177; 0.5; p &lt; 0.05). Athletes in the groups from 51 to 60 years and 61 to 70 years presented higher maximum oxygen consumption values predicted for their age as compared with the group aged between 31 to 40 (158 &#177; 1; 172 &#177; 3 versus 135 &#177; 0.4; p &lt; 0.05).</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>One of the echocardiographic criteria used to differentiate pathological ventricular hypertrophy from physiological hypertrophy is the increase in relative wall thickness (RWT)30. In our study, 11% of the runners presented increased RWT values, which suggests concentric remodeling, i.e., increased wall thickness relative to the left ventricular diastolic diameter. It is unlikely that the type of physical training should have influenced this cardiac adaptation, once long-distance running is a stimulus to excentric cardiac remodeling3. It is more likely that concentric hypertrophy may be due to the fact that 75% of the runners with increased RWT are hypertensive. Vinereanu et al.30, in a comparative study between pathological and physiological hypertrophy, demonstrated significant differences in RWT between athletes and normal control subjects (0.46 &#177; 0.06 versus 0.38 &#177; 0.05, p &lt; 0.05, respectively), as well as between athletes, hypertensive patients and patients with hypertrophic cardiomyopathy (0.46 &#177; 0.06 versus 0.56 &#177; 0.09 versus 0.72 &#177; 0.13, p &lt; 0.01, respectively). These results demonstrate that RWT in pathological conditions is much more accentuated than the RWT observed in athletes. It is worth noticing that, although the electrocardiographic analysis has evidenced left ventricular hypertrophy in 33% of the athletes, only 7% had this diagnosis confirmed by left ventricular mass index values &gt; 134 g/m2. These results suggest higher sensitivity, but low specificity of electrocardiogram to determine ventricular hypertrophy in athletes, which makes the echocardiogram a fundamental test to allow better stratification of cardiac adaptations caused by physical training. In fact, although the electrocardiogram is considered a reference standard for the noninvasive diagnosis of arrhythmias and conduction disorders, its specificity is low for the detection of structural alterations, and may generate false-positive results and overestimate the incidence of left ventricular hypertrophy in athletes.</p>
      <p>As regards the ventricular systolic function, it is known that there is no change triggered by physical training<sup>13,28</sup> of moderate and high intensity. However, in three athletes we found ejection fraction values below the lower normal limit, and we verified cardiovascular disease in two of these cases. One athlete had dilated myocardiopathy of Chagasic etiology and another had myocardiopathy secondary to arterial hypertension. It is important to stress that none of them was aware of the disease before the assessment. Although there was a low percentage of athletes (4%) with ejection fraction below the lower normal limit, this result stresses the need of clinical assessment of athletes before they are deemed fit for competitive sports. The presence of ventricular dysfunction, in these cases, did not prevent these athletes from showing good physical performance in training and competitions to that point. </p>
      <p>The decrease in chronotropic response to more intense exertion after the age of 31 suggests that beta-adrenergic responsivity decrease with age<sup>31</sup>. This alteration has been explained by the impairment of post-receptor adrenergic signaling with age32. Curiously enough, the athletes presented a higher percentage value of predicted heart rate for the age as of the age of 41. These results confirm that heart rate estimation for age based on the formula 220 &#150; age<sup>19</sup> underestimates the maximum absolute heart rate of runners above 41 years of age<sup>33</sup>.</p>
      <p>Despite the significant decrease of absolute oxygen consumption at the anaerobic threshold in the group from 51 to 60 years, the percentage values of oxygen consumption remain unchanged in older runners. These results suggest a delay in the beginning of metabolic acidosis and an increase in oxidation efficiency in these athletes<sup>16,34-36</sup>. The fact that we did not observe significant difference in absolute oxygen consumption at the anaerobic threshold in runners aged between 61 and 70 years is probably due to the small number of athletes in this age group. Similar results were observed at the respiratory compensation point. As of the age of 41, we observed a decrease in the absolute value of oxygen consumption, while the percentage values of oxygen consumption relative to the peak of exertion remain unchanged. These results are additional evidence of the effects of physical training on the maintenance of oxidation capacity even with aging<sup>16,37</sup>.</p>
      <p>Additionally, results of previous studies show that aerobic physical training causes an increase in the specific activity of oxidizing enzymes of skeletal muscles<sup>38</sup> and greater efficacy in the use of free fatty acids through beta-oxidation. Additionally, it causes an increase in the distribution of oxidative muscle fibers (Typo I)<sup>39,40</sup>.</p>
      <p>Our runners did not present extremely high values of peak oxygen consumption, unlike those described by other authors<sup>35,41,42</sup>. In previous studies, highly trained athletes<sup>35</sup> and especially long distance runners (marathonists)<sup>42</sup> were assessed, which favors the development of greater aerobic capacity. Additionally, Fagard et al<sup>41</sup> described a volume of training of runners that ranged from 69 km/week to 167 km/week, a higher level of training of these athletes as compared to our athletes. Therefore, this difference between our study and others may be explained by the period of physical training that our athletes were engaged in, since not all of them were in a competitive period, this being so because only 16% of our sample were comprised of world-class runners, or else because of genetic differences<sup>40,43</sup>. Although peak oxygen consumption decreases significantly after the age of 41, the percentage value predicted for the age was significantly higher in older age groups. This demonstrates that the effects of physical training on maximum functional capacity are independent of age<sup>31,44-46</sup>.</p>
      <p>Limitations of the study - We recognize that our study has some limitations including the fact that the sample relates to athletes of a specific outpatient facility, and that our data cannot be extrapolated to other populations of athletes. Additionally, the period of physical training of the athletes was not controlled, and the athletes with metabolic or cardiovascular alterations were not excluded from the study. Although we recognize that these decisions may have influenced our results, our aim was to describe the population of athletes registered at the Sport and Exercise Cardiology Outpatient Facility of a tertiary hospital of the City of S&#227;o Paulo and, with this, provide cardiologists and health practitioners with the characteristics of long-distance runners who seek these cardiology outpatient facilities. The number of athletes per age group is still small, but is enough to guide other studies in the area. </p>
      <p>Future outlook - These results, although preliminary, may help cardiologists gain knowledge on the normal values for the morphology and functioning of the heart of Brazilian long-distance runners in different age groups. Additionally, these results may anticipate values of oxygen consumption and heart rate in different phases of maximum progressive exercise in these athletes.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>References</bold>
      </p>
      <p>
        <fn id="end-body2" fn-type="corresp">
          <label>
            <bold>Mailing Address:</bold>
          </label>
          <p> Luciene Ferreira Azevedo</p>
          <p> Incor - Unidade de Reabilita&#231;&#227;o Cardiovascular e Fisiologia do Exerc&#237;cio</p>
          <p>Av. Dr. En&#233;as C. Aguiar, 44 - Bl. 02 - Andar (-1)</p>
          <p> 05403-000 - S&#227;o Paulo, SP </p>
          <p> E-mail: </p>
          <p>
            <email xlink:href="expluciene@incor.usp.br">expluciene@incor.usp.br</email>
          </p>
        </fn>
      </p>
      <p>Manuscript received on September 02, 2005; revised manuscript received December 20, 2005; accepted on January 12, 2006.</p>
    </body>
  </sub-article>
</article>
